Epidemiologic Methods in Studies of Osteoporosis

Osteoporosis, Two-Volume Set

Volumn , Issue , 2008, Pages 645-666

  Sowers, MaryFran ^a   Karvonen Gutierrez, Carrie A ^a  

^a UNIVERSITY OF MICHIGAN SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84884076608     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-012370544-0.50027-6     Document Type: Chapter

References (63)

1. Cooper C., Campion G., Melton L.J. Hip fractures in the elderly: A world-wide projection. Osteoporos Int 1992, 2:285-289.
2. Albright F., Bloomberg E., Smith P.H. Postmenopausal osteoporosis. Trans Assoc Am Physicians 1940, 55:298-305.
3. Lindsay R., Hart D.M., MacLean A., Clark A.C., Kraszewski A., Garwood J. Bone response to termination of oestrogen treatment. Lancet 1978, 1:1325-1327.
4. Christiansen C., Christiansen M.S., Transbol I. Bone mass in postmenopausal women after withdrawal of oestrogen/gestagen replacement therapy. Lancet 1981, 1:459-461.
5. Walker-Bone K., Walter G., Cooper C. Recent developments in the epidemiology of osteoporosis. Curr Opin Rheumatol 2002, 14:411-415.
6. Maggi S., Kelsey J.L., Litvak J., Heyse S.P. Incidence of hip fractures in the elderly: A cross-national analysis. Osteoporos Int 1991, 1:232-241.
7. Cummings S.R., Cauley J.A., Palermo L., Ross P.D., Wasnich R.D., Black D., Faulkner for the Study of Osteoporotic Fractures Research Group K.G. Racial differences in hip axis lengths might explain racial differences in rates of hip fracture. Osteoporos Int 1994, 4:226-229.
8. Schwartz A.V., Kelsey J.L., Maggi S., Tuttleman M., Ho S.C., Jonsson P.V., Poor G., Sisson de Castro J.A., Xu L., Matkin C.C., Nelson L.M., Heyse S.P. International variation in the incidence of hip fractures: Cross national project on osteoporosis for the World Health Organization Program for Research on Aging. Osteoporos Int 1999, 9:242-253.
9. Lau E.M.C., Lee J.K., Suriwongpaisal P., Saw S.M., Das De S., Khir A., Sambrook P. The incidence of hip fracture in four Asian countries: The Asian Osteoporosis Study (AOS). Osteoporos Int 2001, 12:239-243.
10. Bernsten G.K., Tollan A., Magnus J.H., Sogaard A.J., Ringberg T., Fonnebo V. The Tromso Study: Artifacts in forearm bone densitometry-Prevalence and effect. Osteoporos Int 1999, 10:425-432.
11. Honkanen R., Tuppurainen M., Kroger H., Alhava E., Saarikoski S. Relationships between risk factors and fractures differ by type of fracture: A population-based study of 12,192 perimenopausal women. Osteoporos Int 1998, 8:25-31.
12. Schlienger R.G., Kraenzlin M.E., Jick S.S., Meier C.R. Use of β-blockers and risk of fractures. JAMA 2004, 292:1326-1332.
13. Wengreen H.J., Munger R.G., West N.A., Cutler D.R., Corcoran C.D., Zhang J., Sassano N.E. Dietary protein intake and risk of osteoporosis: Hip fracture in elderly residents of Utah. J Bone Miner Res 2004, 19:537-545.
14. Miettinen O.S. The "case-control" study: Valid selection of subjects. J Chronic Dis 1985, 38:543-548.
15. Paganini-Hill A., Ross R.K., Gerkins V.R., Henderson B.E., Arthur M., Mack T.M. Menopausal estrogen therapy and hip fractures. Ann Intern Med 1981, 95:28-31.
16. Grisso J.A., Kelsey J.L., O'Brien L.A., Miles C.G., Sidney S., Maislin G., LaPann K., Moritz D., Peters for the Hip Fracture Study Group B. Risk factors for hip fracture in men. Am J Epidemiol 1997, 145:786-793.
17. Grisso J.A., Kelsey J.L., Strom B.L., O'Brien L.A., Maislin G., LaPann K., Samelson L., Hoffman for the Northeast Hip Fracture Study Group S. Risk factors for hip fracture in Black women. N Engl J Med 1994, 330:1555-1559.
18. Weiss N.S., Ure C.L., Ballard J.H., Williams A.R., Daling J.R. Decreased risk of fractures of the hip and lower forearm with postmenopausal use of estrogen. N Engl J Med 1980, 303:1195-1198.
19. Kreiger N., Gross A., Hunter G. Dietary factors and fracture in postmenopausal women: A case-control study. Int J Epidemiol 1992, 21:953-958.
20. Grisso J.A., Kelsey J.L., Strom B.L., Chiu G.Y., Maislin G., O'Brien L.A., Hoffman S., Kaplan for the Northeast Hip Fracture Study Group F. Risk factors for falls as a cause of hip fracture in women. N Engl J Med 1991, 324:1326-1331.
21. Sackett D.L. Bias in analytic research. J Chronic Dis 1979, 32:51-63.
22. Austin H., Hill H.A., Flanders W.D., Greenberg R.S. Limitations in the application of case-control methodology. Epidemiol Rev 1994, 16:65-76.
23. Bagger Y.Z., Tanko L.B., Alexandersen P., Hansen H.B., Qin G., Christiansen C. The long-term predictive value of bone mineral density measurements for fracture risk is independent of the site of measurement and the age at diagnosis: Results from the Prospective Epidemiological Risk Factors study. Osteoporos Int 2006, 17:471-477.
24. Sowers M.R., Jannausch M., McConnell D., Little R., Greendale G.A., Finkelstein J.S., Neer R.M., Johnston J., Ettinger B. Hormone predictors of bone mineral density changes during the menopausal transition. J Clin Endocrinol Metab 2006, 91:1261-1267.
25. Barrett-Connor E., Chang J.C., Edelstein S.L. Coffeeassociated osteoporosis offset by daily milk consumption. The Rancho Bernardo Study. JAMA 1994, 271:280-283.
26. Petitti D.B., Sidney S. Hip fracture in women. Incidence, in-hospital mortality, and five-year survival probabilities in members of a prepaid health plan. Clin Orthop Relat Res 1989, 246:150-155.
27. Hernandez-Avila M., Colditz G.A., Stampfer M.J., Rosner B., Speizer F.E., Willett W.C. Caffeine, moderate alcohol intake, and risk of fractures of the hip and forearm in middleaged women. Am J Clin Nutr 1991, 54:157-163.
28. Bauer D.C., Browner W.S., Cauley J.A., Orwoll E.S., Scott J.C., Black D.M., Tao J.L., Cummings for the Study of Osteoporotic Fractures Research Group S.R. Factors associated with appendicular bone mass in older women. Ann Intern Med 1993, 118:657-665.
29. Cuddihy M.T., Gabriel S.E., Crowson C.S., O'Fallon W.M., Melton L.J. Forearm fractures as predictors of subsequent osteoporotic fractures. Osteoporos Int 1999, 9:469-475.
30. Snelling A.M., Crespo C.J., Schaeffer M., Smith S., Walbourn L. Modifiable and nonmodifiable factors associated with osteoporosis in postmenopausal women: Results from the Third National Health and Nutrition Examination Survey, 1988-1994. J Womens Health Gend Based Med 2001, 10:57-65.
31. Barker M.E., McCloskey E., Saha S., Gossiel F., Charlesworth D., Powers H.J., Blumsohn A. Serum retinoids and beta-carotene as predictors of hip and other fractures in elderly women. J Bone Miner Res 2005, 20:913-920.
32. Prentice R.L. A case-cohort design for epidemiologic cohort studies and disease prevention trials. Biometrika 1986, 73:1-11.
33. Cummings S.R., Browner W.S., Bauer D., Stone K., Ensrud K., Jamal S., Ettinger for the Study of Osteoporotic Fractures Research Group B. Endogenous hormones and the risk of hip and vertebral fractures among older women. N Engl J Med 1998, 339:733-738.
34. Jackson R.D., LaCroix A.Z., Gass M., Wallace R.B., Robbins J., Lewis C.E., Bassford T., Beresford S.A.A., Black H.R., Blachette P., Bonds D.E., Brunner R.L., Brzyski R.G., Caan B., Cauley J.A., Chlebowski R.T., Cummings S.R., Granek I., Hays J., Heiss G., Hendrix L., Howard V., Hsia J., Hubbell A., Johnson C., Judd H., Kotchen M., Kuller H., Langer D., Lasser L., Limacher C., Ludlam S., Manson E., Margolis L., McGowan J., Ockene K., O'Sullivan J., Phillips L., Prentice L., Sarto E., Stefanick L., Van Horn L., Wactawski-Wende J., Whitlock E., Anderson L., Assaf R., Barad D. for the Women's Health Initiative Investigators, Calcium plus vitamin D supplementation and the risk of fractures. N Engl J Med 2006, 354:669-683.
35. Cauley J.A., Robbins J., Chen Z., Cummings S.R., Jackson R.D., LaCroix A.Z., LeBoff M., Lewis C.E., McGowan J., Neuner J., Pettinger M., Stefanick M.L., Wactawski- Wende J., Watts for the Women's Health Initiative Investigators N.B. Effects of estrogen plus progestin on risk of fracture and bone mineral density: The Women's Health Initiative randomized trial. JAMA 2003, 290:1729-1738.
36. An Assessment of the NIH Women's Health Initiative 1993, Institute of Medicine Committee to Review the NIH Women's Health Initiative, National Academy Press, Washington, D.C. S. Thaul, D. Hotra (Eds.).
37. Hulley S., Grady D., Bush T., Furberg C., Herrington D., Riggs B., Vittinghoff E. Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women: Heart and Estrogen/ Progestin Study (HERS) Research Group. JAMA 1998, 280:605-613.
38. Manson J.E., Hsia J., Johnson K.C., Rossouw J.E., Assaf A.R., Lasser N.L., Trevisan M., Black H.R., Heckbert S.R., Detrano R., Strickland O.L., Wong N.D., Crouse J.R., Stein E., Cushman for the Women's Health Initiative Investigators M. Estrogen plus progestin and the risk of coronary heart disease. N Engl J Med 2003, 349:523-534.
39. Sowers M.R., Shapiro B., Gilbraith M.A., Jannausch M. Health and hormonal characteristics of premenopausal women with lower bone mass. Calcif Tissue Int 1990, 47:130-135.
40. Felson D.T., Zhang Y., Hannan M.T., Kiel D.P., Wilson P.W., Anderson J.J. The effect of postmenopausal estrogen therapy on bone density in elderly women. N Engl J Med 1993, 329:1141-1146.
41. Forsen L., Bjorndal A., Bjartveit K., Edna T.H., Holmen J., Jessen V., Westberg G. Interaction between current smoking, leanness, and physical inactivity in the prediction of hip fracture. J Bone Miner Res 1994, 9:1671-1678.
42. Steinbuch M., Youket T.E., Cohen S. Oral glucocorticoid use is associated with an increased risk of fracture. Osteoporos Int 2004, 15:323-328.
43. Schlesselman J.J. Case-Control Studies 1982, Oxford University Press, New York.
44. Selvin S. Statistical Analysis of Epidemiologic Data 2004, Oxford University Press, New York.
45. Kelsey J.L., Whittemore A.S., Evans A.S., Thompson W.D. Methods in Observational Epidemiology 1996, Oxford University Press, New York. 2nd ed.
46. van Staa T.P., Leufkens H.G.M., Abenhaim L., Zhang B., Cooper C. Use of oral corticosteroids and risk of fractures. J Bone Miner Res 2000, 15:993-1000.
47. Tremollieres F.A., Pouilles J.M., Ribot C. Withdrawal of hormone replacement therapy is associated with significant vertebral bone loss in postmenopausal women. Osteoporos Int 2001, 12:385-390.
48. Chapuy M.C., Arlot M.E., Duboeuf F., Brun J., Crouzet B., Arnaud S., Delmas P.D., Meunier P.J. Vitamin D3 and calcium to prevent hip fractures in the elderly women. N Engl J Med 1992, 327:1637-1642.
49. Schindler A.E., Ebert A., Friedrich E. Conversion of androstenedione to estrogen by human tissue. J Endocrinol Metab 1972, 35:627-630.
50. Cummings S.R., Nevitt M.C. A hypothesis: The causes of hip fractures. J Gerontol 1989, 44:M107-M111.
51. Lilienfeld A.M. Epidemiological methods and inferences in studies of non-infectious diseases. Public Health Rep 1957, 72:51-60.
52. Zhang X., Shu X.O., Li H., Yang G., Li Q., Gao Y.T., Zheng W. Prospective cohort study of soy food consumption and risk of bone fracture among postmenopausal women. Arch Intern Med 2005, 165:1890-1895.
53. Cumming R.G. Calcium intake and bone mass: A quantitative review of the evidence. Calcif Tissue Int 1990, 47:194-201.
54. Lindsay R. Hormone replacement therapy for prevention and treatment of osteoporosis. Am J Med 1993, 95:37S-39S.
55. Fleiss J.F. The Design and Analysis of Clinical Experiments 1999, Wiley, New York.
56. Greenland S. The effect of misclassification in the presence of covariates. Am J Epidemiol 1980, 112:564-569.
57. Weinberg C.R., Umbach D.M. and S. Greenland, When will nondifferential misclassification of an exposure preserve the direction of a trend? Am J Epidemiol 1994, 140:565-571.
58. Paganini-Hill A., Ross R.K. Reliability of recall of drug usage and other health-related information. Am J Epidemiol 1982, 116:114-122.
59. O'Neill T.W., Cooper C., Cannata J.B., Diaz Lopez J.B., Hoszowski K., Johnell O., Lorenc R.S., Nilsson B., Raspe H., Stewart O., Silman A.J. for the European Vertebral Osteoporosis (EVOS) Group, Reproducibility of a questionnaire on risk factors for osteoporosis in a multicentre prevalence survey: The European Vertebral Osteoporosis Study. Int J Epidemiol 1994, 23:559-565.
60. Schott A.M., Hans D., Sornay-Rendu E., Delmas P.D., Meunier P.J. Ultrasound measurements on os calcis: Precision and age-related changes in a normal female population. Osteoporos Int 1993, 3:249-254.
61. Liu K., Stamler J., Dyer A., McKeever J., McKeever P. Statistical methods to assess and minimize the role of intraindividual variability in obscuring the relationship between dietary lipids and serum cholesterol. J Chronic Dis 1978, 31:399-418.
62. Rosner B.A., Willett W.C. Interval estimates for correlation coefficients corrected for within-person variation: Implications for study design and hypothesis testing. Am J Epidemiol 1988, 127:377-386.
63. Sowers M. Clinical epidemiology and osteoporosis: Measures and their interpretation. Endocrinol Metab Clin North Am 1997, 26:219-231.